What were the key takeaways from The Mosaic's earnings call?

What were the key takeaways from The Mosaic’s earnings call?

Did The Mosaic beat or miss consensus estimates last quarter?

What is The Mosaic's gross profit margin?

What is the revenue and EPS growth rate for The Mosaic year over year?

What is The Mosaic's latest dividend and current dividend yield?

What factors drove the changes in The Mosaic's revenue and profit?

What guidance did The Mosaic's management provide for the next earnings period?

- **Strong Q3 Results**: Net income up 238% YoY to $411 million, EBITDA nearly double at $806 million, fueled by Brazil’s Mosaic Fertilizantes and higher fertilizer prices.
- **Operational Progress**: U.S. phosphate production at 1.8 million tonnes (Q3), with 3 straight quarters of sequential improvement. Brazil business resilient despite credit challenges.
- **Cost Savings & Divestments**: $150 million in cost savings achieved, $250 million target by 2026. Taquari potash mine and Patos de Minas divestments reduce capital intensity.
- **2026 Outlook**: Free cash flow improvement expected, with focus on operational efficiency, ARO/legal reserve reductions, and disciplined capital allocation.

**【CEO Summary Section】**
- **Q3 Financial Highlights**: Net income of $411 million (vs. $122 million YoY), adjusted EBITDA of $806 million (vs. $448 million YoY), driven by higher prices and strong Brazil performance.
- **Asset Health Improvements**: U.S. phosphate production improved sequentially, with trailing 3-month volume at 1.8 million tonnes. Brazil’s Mosaic Fertilizantes achieved $241 million EBITDA, above guidance.
- **Cost Discipline**: $150 million in cost savings achieved, on track for $250 million by 2026. Divestments (Taquari potash mine, Patos de Minas) freed up capital for higher returns.
- **Market Outlook**: Global potash demand strong, especially in Eastern Hemisphere. Phosphate affordability concerns moderating prices, but long-term demand supported by LFP batteries and China’s domestic use.

**【CFO Financial Commentary】**
- **Cash Flow Challenges**: Q3 operating cash flow of $229 million due to $400 million working capital increase (inventory buildup, higher raw material prices). 2025 cash flow expected below intrinsic levels, but 2026 improvement anticipated with stable raw material prices.
- **Cost Leverage**: Phosphate cash conversion costs at $131/tonne (Q3), targeting $100-105/tonne with higher production. Potash unit costs stable at $71/tonne, near-term guidance of low to mid-70s.
- **Capital Allocation**: 2026 focus on free cash flow growth, with ARO/legal reserves declining and operational efficiency gains.

**【Q&A Key Highlights】**
- **Phosphate Production Progress**: 3 consecutive quarters of sequential improvement, Q4 guidance of 1.7-1.9 million tonnes. Challenges include operational consistency and institutional knowledge gaps.
- **Fertilizantes Performance**: Q3 EBITDA of $241 million (vs. $200 million guide), but Q4 expected decline due to lower prices, compressed margins, and seasonal factors.
- **Sulfur Price Risks**: Higher sulfur costs driven by Russia export restrictions, but stripping margins still above historical norms.
- **2026 Outlook**: Improved cash flow, normalized production rates, and capital reallocation to higher-return projects.

The Mosaic Company (MOS) Q3 2025 Earnings Call Transcript

- **Operational Turnaround**: Brazil cost reductions ($106M to date) and U.S. phosphate reliability drive Q3 EBITDA growth. 
- **Market Strength**: Global phosphate demand (India, Brazil) and tight potash supply support prices. Full-year potash guidance raised. 
- **Cost Efficiency**: Q3 idle/turnaround costs to drop, phosphate unit costs to improve with higher volumes. 
- **Strategic Growth**: Brazil expansion, Biosciences EBITDA-positive by Q4, and China business doubling H1. 
- **Q3 Outlook**: EBITDA expected to be strongest in years, with sequential improvement from Q2. 


**【CEO Opening Remarks】**
- **Operational Improvements**: Brazil's performance is strong, and U.S. phosphate production reliability is restored post-maintenance. Q2 net income was $411M, up from a loss in 2024, with phosphate and potash markets tightening. 
- **Market Outlook**: Global phosphate demand remains robust, with India and Brazil driving imports. Potash prices are stable due to supply constraints. Full-year potash production guidance raised to 9.3-9.5M tonnes. 
- **Cost Efficiency**: Brazil's cost reduction efforts saved $106M, targeting $150M by year-end. Unit costs in phosphate will improve as volumes rise. 
- **Strategic Investments**: New Palmeirante facility adds 1M tonnes capacity in Brazil. Mosaic Biosciences revenues doubled YoY, expected to contribute to EBITDA in Q4. 

**【CFO Financial Commentary】**
- **Q2 Results**: Adjusted EBITDA $566M vs. $584M in 2024. Net income $411M vs. loss in 2024, driven by FX gains and asset write-offs. 
- **Cost Dynamics**: Phosphate idle/turnaround costs $34M (vs. $100M annualized norm). Potash costs $75/tonne, up due to lower absorption. Brazil's EBITDA $150M despite bad debt. 
- **Q3 Guidance**: Turnaround costs to decline. Phosphate volumes to rise, unit costs to drop. Potash production to increase. Brazil EBITDA >$200M if volumes stabilize. 

**【Q&A Highlights】**
- **Production Risks**: Hurricane prep complete; no major maintenance delays. Brazil credit risks managed via selective customer focus. 
- **Tariffs Impact**: U.S. phosphate imports down 20% YoY due to tariffs. Minimal direct impact on Mosaic's raw material costs. 
- **Fertilizantes Growth**: Brazil's northern expansion and Biosciences new products drive long-term EBITDA to $1B+. China business doubled H1, targeting further growth. 
- **Q3 EBITDA Expectation**: Significant sequential improvement due to volume rise, cost decline, and market tightness. Phosphate margins to expand, potash stable. 


The Mosaic Company (MOS) Q2 2025 Earnings Call Transcript

- **Revenue Growth**: Q1 net income of $238 million and EBITDA of $544 million reflect strong phosphate and potash pricing, exceeding guidance.
- **Operational Efficiency**: Phosphate conversion costs target $95-$100/ton by year-end, with Esterhazy potash project adding 400,000 tons annually.
- **Market Leadership**: Brazil's Mosaic Fertilizantes segment leads with 10% volume growth, while Mosaic Biosciences doubles revenue YoY.
- **Cost Savings**: $90 million of $150 million cost reduction achieved, with SG&A down $16 million YoQ.
- **Strategic Growth**: $70 million 2025 Biosciences revenue target with 60% gross margin on proprietary products.


**【CEO Summary Section】**
- **Strong Market Fundamentals**: Phosphate and potash prices are rising due to supply constraints and robust global demand. Q1 net income was $238 million, with adjusted EBITDA at $544 million, driven by higher phosphate and potash prices.
- **Operational Progress**: Phosphate production costs are expected to decline as production normalizes, with Q1 phosphate production at 1.4 million tons. The Esterhazy potash project is on track to add 400,000 tons annually.
- **Strategic Growth**: Brazil's Mosaic Fertilizantes segment saw 10% year-over-year volume growth, and Mosaic Biosciences revenue doubled YoY. The Palmeirante blend plant in Brazil is expected to contribute additional volumes this year.

**【CFO Financial Commentary】**
- **Financial Highlights**: Q1 GAAP net income was $238 million, with phosphate and potash realized prices exceeding guidance ($623/ton for phosphate, $223/ton for potash). Mosaic Fertilizantes EBITDA rose to $122 million, despite FX headwinds.
- **Cost Management**: SG&A expenses declined $16 million YoQ, with $90 million of $150 million annual cost savings achieved. Phosphate conversion costs are expected to fall to $95-$100/ton by year-end.
- **Cash Flow**: Q1 cash flow was constrained by seasonal working capital, but free cash flow is expected to improve in H2. CapEx for 2025 is $1.2-$1.3 billion, with focus on production reliability and growth projects.

**【Market Update】**
- **Global Demand**: Brazil's fertilizer shipments are expected to exceed 47 million tons in 2025, up 2% YoY. India's phosphate demand is set to recover to 6.4 million tons, a 40% YoY increase. U.S. spring season demand remains stable, but affordability challenges may persist.
- **Supply Constraints**: China's lithium iron phosphate (LFP) production growth is limiting phosphate exports, while potash supply reductions from Russia, China, and Chile support prices.
- **Biologicals Growth**: Mosaic Biosciences' Neptunion biostimulant launched in China, with trials in India and Brazil. The segment is on track for $70 million in 2025 revenue and $200 million EBITDA by 2030.

**【Q&A Key Takeaways】**
- **Production Costs**: Phosphate unit costs will decline as production ramps up, with Q2-Q4 targeting $95-$100/ton. Potash costs are expected to improve with Esterhazy project completion.
- **Tariff Impact**: Ammonia imports remain tariff-free, with minimal exposure to U.S. trade policies. Brazil's market strength offsets U.S. affordability concerns.
- **Capital Allocation**: Non-core assets like Carlsbad and Taquari are being evaluated for divestiture to redeploy capital into higher-margin opportunities.


The Mosaic Company (MOS)-7 May 25-2025 Q1 Earnings call transcript

- **Market Strength**: 2025 outlook driven by strong crop prices, tight phosphate supply, and potash demand despite geopolitical risks. 
- **Operational Excellence**: Potash production efficiency gains (Esterhazy expansion), Brazil EBITDA rebounding to $120M pre-FX. Phosphate 2025 guidance reflects recovery from 2024 hurricane impacts. 
- **Cost Efficiency**: $150M cost savings target on track, with Brazil leading with $35M recurring savings. 
- **Strategic Action**: Asset sales (Patos de Minas, Ma'aden) and biosciences growth (Mosaic Biosciences doubling revenue in 2024). 
- **Risk Management**: Tariffs on Canadian potash unlikely to dampen demand due to crop price support; Brazil credit risks mitigated by customer diversification.

**【CEO Summary Section】**
- **Market Outlook**: Agriculture fundamentals are improving, with strong crop prices incentivizing farmers to maximize yields. Potash demand is expected to remain strong due to affordability and geopolitical supply constraints (e.g., Laos, China, Belarus). Phosphate supply remains tight, driven by biofuel and battery demand.
- **Operational Progress**: 
  - Potash: Esterhazy mine efficiency improvements (e.g., Hydrofloat project adding 400,000 tonnes/year) and Belle Plaine at full production capacity. 
  - Phosphate: U.S. production recovery delayed by hurricanes, but 2025 guidance of 7.2-7.6M tonnes reflects expected improvement. Brazil operations resilient despite market headwinds, with Q4 EBITDA of $82M.
- **Strategic Actions**: 
  - Asset Reallocation: Pending sale of Patos de Minas site in Brazil and exploration of alternatives for Carlsbad potash mine. 
  - Growth Engines: Mosaic Biosciences revenue doubled in 2024, targeting similar growth in 2025 with new products like PowerCoat and BioPath.

**【CFO Financial Commentary】**
- **Q4 2024 Results**: Net income $169M, adjusted EBITDA $594M. Potash and phosphate pricing strong, Brazil segment EBITDA $82M (after $35M FX loss). 
- **Cost Control**: $150M cost reduction target on track, with $35M recurring savings in Brazil (e.g., ceasing phosphate rock imports). 
- **Capital Allocation**: 2024 CapEx reduced by $200M; 2025 flat CapEx to address reliability issues. Discontinuing monthly price/volume releases due to feedback.
- **FX Impact**: Q4 $390M FX loss (Brazil real weakness, Canada dollar decline). Brazil EBITDA reduced by $35M, but underlying performance ~$120M pre-FX adjustments.

**【Q&A Key Themes】**
- **Production Recovery**: Phosphate 2024 loss of 700,000 tonnes due to weather; 2025 guidance of 7.2-7.6M tonnes reflects sulfuric acid turnaround delays. Potash supply constrained by China, Belarus, and Laos, limiting upside. 
- **Asset Sales**: Ma'aden transaction ($522M gain) and Patos de Minas sale highlight capital reallocation. Carlsbad potash mine alternatives under evaluation. 
- **Tariffs & Pricing**: Canadian potash tariffs (~25%) likely borne by U.S. farmers, but affordability supports demand. Q1 potash prices up $40/tonne, more gains expected in Q2. 
- **Cash Flow**: 2024 cash shortfall due to production delays, but 2025 expects to cover dividend and CapEx with operating cash flow. 
- **Brazil Risks**: Shift to low-risk customers (e.g., co-ops, end-users) mitigates credit issues; 2025 focus on cost improvements and FX hedging.

MOS

MOS fundamentals

Earnings Call

You can ask Aime